From the November 2020 issue of HealthCare Business News magazine


Brain abnormalities found on MR scans of almost half of COVID-19 patients in ICU
A study published in the journal Radiology in May found that close to half of COVID-19 patients admitted to ICUs in Turkey showed signs of brain abnormalities on MR scans.

The discovery was made by neuroradiologists at Istanbul University-Cerrahpasa, who assert that the findings validated symptoms already identified for those with the disease, particularly symptoms related to the nervous system.
“Recent evidence highlights a relatively high percentage (36%) of central nervous system symptoms including headache, altered mental status, acute cerebrovascular disease and epilepsy in patients with COVID-19,” said the authors in their report. “The rate of neurological symptoms is higher in patients with more severe respiratory disease status. The relatively high percentage of neurologic symptoms is concordant with studies showing neurotropism of coronavirus.”

The purpose of the study was to evaluate the neurological condition of COVID-19 patients, as current literature on the subject is limited. Six percent of patients assessed experienced acute stroke, while another 15% had an altered state of mind. The authors believe one factor responsible is the cytokine storm, in which the body attacks its own cells and tissues in addition to fighting off the virus.

The researchers performed MR exams on 235 COVID-19 patients in the ICUs of two academic and six non-academic-affiliated hospitals. Of them, 50 (21%) developed neurological symptoms.

All abnormalities were found in different areas of the brain, including the frontal lobe, parietal lobe, occipital lobe, temporal lobe, insular cortex and cingulate gyrus. Diagnoses that included autoimmune encephalitis, seizure, hypoglycemia and hypoxia were the main differentiator of the group, as it can be accompanied by cortical microhemorrhages and blood-brain barrier breakdown. The findings highlight that COVID-19 may result in infectious or autoimmune encephalitis due to its neurotropic potential.

The authors claim that the study may help increase awareness of a possible relationship between SARS-CoV-2 and neurological abnormalities in infected patients, especially those in the ICU. They warn, however, that comorbid conditions must be accounted for as confounding factors in the neurological abnormalities found, including diabetes mellitus, prolonged ICU stays, and respiratory distress with hypoxia.

November 2020 Magazine

Read more stories from the November 2020 issue

MRI Homepage